Fundraising FoxNanoGhost
1 known investors
Find your way into NanoGhost
Sign up to see every warm intro you have to NanoGhost
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NanoGhost team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NanoGhost develops a drug targeting platform called Nano-Ghosts (NGs), nanovesicles made from the cell membrane of mesenchymal stem cells that target cancer and inflammation sites and can carry various therapeutic loads. The biotech company's technology originates from research at the Technion – Israel Institute of Technology.
Founders & leadership
MM
Marcelle MachlufProfessor (technology inventor)
Investors · 1
aMoonlisted by aMoonRa'anana
How we know: aMoon's portfolio page · funding news · Not right? Tell us
Frequently asked questions
- What does NanoGhost do?
- NanoGhost develops a drug targeting platform called Nano-Ghosts (NGs), nanovesicles made from the cell membrane of mesenchymal stem cells that target cancer and inflammation sites and can carry various therapeutic loads. The biotech company's technology originates from research at the Technion – Israel Institute of Technology.
- Who founded NanoGhost?
- NanoGhost was founded by Marcelle Machluf.
- Who are NanoGhost's investors?
- NanoGhost's investors include aMoon.